Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/15/26 19:18 | 9/15/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Goncalves Joana | CA | O | Chief Me | 10 | S.d | -4,543 | 62.64 | 0 | -73 | 34 | D | |||||||||||||||
9/15/26 19:17 | 9/11/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Agarwal Arjun | CA | O | SVP,Fina | 7 | S.dm | -4,278 | 82.05 | 0 | -52 | 19 | D | |||||||||||||||
9/15/26 19:15 | 9/15/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Klein Lawrence Otto | CA | DO | CEO | 4 | S.d | -7,314 | 90.40 | 0 | -81 | 927 | D | |||||||||||||||
9/15/26 19:14 | 9/15/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Quinlan Paul T | CA | O | GC | 4 | S.d | -5,822 | 106.82 | 0 | -55 | 32 | D | |||||||||||||||
9/15/26 19:11 | 9/15/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Sandler Laura Lee | CA | O | COO | 8 | S.d | -1,942 | 55.33 | 0 | -35 | 238 | D | |||||||||||||||
7/1/26 21:30 | 7/1/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Fairmount Funds Management LLC | PA | DT | 1 | S.d | -300,014 | 84.43 | 0 | -3,553 | 3,705 | I | ||||||||||||||||
6/12/26 16:36 | 6/11/26 | ORKA | Health | Drug | Pharmaceutical Preparations | Dambkowski Carl | CA | D | 2 | S.dm | -8,646 | 61.76 | 0 | -140 | 74 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |